Mirum Pharmaceuticals
(NASDAQ:MIRM)
$24.76
-1.07[-4.14%]
At close: May 10
$24.76
0[0.00%]
After Hours: 4:00PM EDT
Q1 2024 Earnings were released on Wed May 8th, after the market close
The most recent conference call was at 16:30 PM, 3 days ago Click to view past webcast
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Mirum Pharmaceuticals Stock (NASDAQ:MIRM), Quotes and News Summary

Mirum Pharmaceuticals Stock (NASDAQ: MIRM) stock price, news, charts, stock research, profile.

Open$25.830
Close$24.760
Volume / Avg.429.935K / 492.742K
Day Range24.570 - 26.130
52 Wk Range23.140 - 35.560
Market Cap$1.167B
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
46
Short Interest
21.18%
Days to Cover18.23

Recent News

$5M Bet On Snowflake? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Wednesday, there were a few notable insider trades.
Avi Kapoor
FDA Approves Mirum's Livmarli For Liver Disease In Kids As Young As 5 Years: Analyst Bullish On Label Expansion Strategy
FDA approves Livmarli by Mirum Pharmaceuticals for cholestatic pruritus in PFIC patients ≥5 years old. Data from Phase 3 MARCH study. Analysts bullish on broader coverage in 2024, with price target raised to $58. Concerns over age restrictions addressed with proposed new formulation."
Vandana Singh
Veradigm, Aehr Test Systems, Saratoga Investment And Other Big Stocks Moving Lower On Wednesday
U.S. stocks traded slightly higher, with the Dow Jones index gaining over 20 points on Wednesday. Shares of Veradigm Inc. (NASDAQ: MDRX) shares fell sharply during Wednesday’s session.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
0
0
0
0
Jan
2
Feb
4
Mar
2
Apr
4
May
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
MIRM
GYRE

FAQ

Q

How do I buy Mirum Pharmaceuticals (MIRM) stock?

A

You can purchase shares of Mirum Pharmaceuticals (NASDAQ: MIRM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Mirum Pharmaceuticals's (MIRM) competitors?

A

Other companies in Mirum Pharmaceuticals’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Centessa Pharmaceuticals (NASDAQ:CNTA), Prothena Corp (NASDAQ:PRTA) and Immatics (NASDAQ:IMTX).

Q

What is the target price for Mirum Pharmaceuticals (MIRM) stock?

A

The latest price target for Mirum Pharmaceuticals (NASDAQ: MIRM) was reported by Morgan Stanley on Friday, May 10, 2024. The analyst firm set a price target for 53.00 expecting MIRM to rise to within 12 months (a possible 114.05% upside). 36 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Mirum Pharmaceuticals (MIRM)?

A

The stock price for Mirum Pharmaceuticals (NASDAQ: MIRM) is $24.76 last updated May 10, 2024 at 4:00 PM EDT.

Q

Does Mirum Pharmaceuticals (MIRM) pay a dividend?

A

There are no upcoming dividends for Mirum Pharmaceuticals.

Q

When is Mirum Pharmaceuticals (NASDAQ:MIRM) reporting earnings?

A

Mirum Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Q

Is Mirum Pharmaceuticals (MIRM) going to split?

A

There is no upcoming split for Mirum Pharmaceuticals.

Q

What sector and industry does Mirum Pharmaceuticals (MIRM) operate in?

A

Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch